WYNNEFIELD PARTNERS SMALL CAP VALUE LP 13D and 13G filings for Lifecore Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-07 4:25 pm Purchase |
2023-01-09 | 13D | Lifecore Biomedical, Inc. LFCR |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP | 5,387,830 17.900% |
461,035 (+9.36%) |
Filing |
| 2023-01-12 5:13 pm Purchase |
2023-01-09 | 13D | Lifecore Biomedical, Inc. LFCR |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP | 4,926,795 16.600% |
2,362,271 (+92.11%) |
Filing |